Two Companies Restart Virus Trials in U.S. After Safety Pauses - The New York Times
AstraZeneca: Thailand delays vaccine rollout over blood clot fears - BBC News
AstraZeneca sells off UK site in Alderley Park, takes $275m hit
AstraZeneca COVID-19 vaccine blood clot risk 'similar' to Pfizer, Spanish study finds | Euronews
Covid has shown the subjective nature of risk perception | Financial Times
Nature, con AstraZeneca lieve aumento dei rischi di una rara malattia del sangue - Biotech - ANSA.it
AstraZeneca's Covid-19 vaccine shows better-than-expected efficacy
Why U.S. Approval of the AstraZeneca Covid-19 Vaccine Is Taking So Long | Smart News | Smithsonian Magazine
AFPgraphics on Twitter: "The Oxford-AstraZeneca vaccine uses a viral-vector to deliver SARS-CoV-2 DNA and activate the immune system @AFP… "
Latest results put Oxford–AstraZeneca COVID vaccine back on track
AstraZeneca's COVID-19 vaccine isn't tied to blood clots, experts say | Science News
AstraZeneca puts Covid-19 vaccine trial on hold over safety concern: Report | World News - Hindustan Times
Covid-19: State regulator reports serious clotting events linked to AstraZeneca jab
Vaccini, prima dose Astrazeneca e seconda Pfizer: il mix funziona. «Risposta immunitaria più potente», studio su Nature
AstraZeneca to seek US approval of COVID vaccine | abc10.com
How the Oxford-AstraZeneca Covid-19 Vaccine Works - The New York Times
Latest results put Oxford–AstraZeneca COVID vaccine back on track
What scientists do and don't know about the Oxford–AstraZeneca COVID vaccine
AstraZeneca на Твитеру: "Our #LGBTQ employee resource group AZplus began with just a few employees who saw an unmet need and grew into a network that supports hundreds of employees. In @nature, @
AstraZeneca vaccine: 'Don't be fobbed off' urges fiancee - BBC News
Clot questions over J&J and AstraZeneca vaccines – European Data News Hub
AstraZeneca has worked out 'winning formula' to boost COVID vaccine's efficacy, says firm's boss | Euronews
AstraZeneca resumes US COVID-19 vaccine trial
Mix-and-match COVID vaccines: the case is growing, but questions remain
France's Pasteur Institute finds two doses of Pfizer or AstraZeneca crucial to beating Delta variant | Euronews
